PO-1200 Development and validation of two Australian models to predict 2-year survival in stage I-III NSCLC

Autor: Vinod, S., Lee, N., Shafiq, J., Field, M., Fiddler, C., Varadarajan, S., Gandhidasan, S., Hau, E.
Zdroj: In Radiotherapy and Oncology August 2021 161 Supplement 1:S996-S997
Databáze: ScienceDirect